Podium presentations

Ethgen O, Terlinden A. Evaluation of   risk-sharing agreements – A real option approach. To be presented as a Workshop at the 17th European   Congress of the International Society for Pharmacoeconomics and Outcomes   Research (ISPOR) – Amsterdam, The Netherlands, November 8-12th,   2014.
Schneider AG, Ethgen O,   Kellum JA, Bagshaw SM, Bellomo R. Dialysis dependence after severe acute   kidney injury: a health economics analysis. Podium presentation at the 31st Annual Meeting of the   International Society of Blood Purification (ISBP) – Bologna, Italy,   September 12-14th, 2013.
Delbecque L, Taquet M, Ethgen   O, Chassany O. When collecting patient data gets electronics: The   upsurge of eHealth and the   importance of BIG DATA to shape modern health care. Workshop at the 16th   European Congress of the International Society for Pharmacoeconomics and   Outcomes Research (ISPOR) – Dublin, Ireland, November 2-6th, 2013.   Congress Program and Schedule of Events, page 137 (W12).
Standaert B, Ethgen O,   Emerson R. Found   the missing link? How to relate cohort models to observed population data. Podium presentation at the 15th   European Congress of the International Society for Pharmacoeconomics and   Outcomes Research (ISPOR) – Berlin, Germany, November 3-7th, 2012.   Value in Health 2012;15:A288.
Standaert B, Ethgen O,   Emerson R. Cost-effectiveness   analysis – Appropriate for all situations? Podium presentation at the 17th International Congress of   the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)   – Washington DC, USA, June 2-6th, 2012. Value in Health   2012;15:A2.
Ethgen O, O’Mahony J. Cohort,   multi-cohort or population model – Why, when and how? Workshop at the 14th European Congress of the   International Society for Pharmacoeconomics and Outcomes Research (ISPOR) –   Madrid, Spain, November 5-8th, 2011. Congress Program and Schedule   of Events, page 120 (W23).
Postma M, Connolly M, Ethgen   O. Productivity   gains – Undervalued and of increasing importance in an era of shrinking   numbers of working age adults? Workshop at the 14th European   Congress of the International Society for Pharmacoeconomics and Outcomes   Research (ISPOR) – Madrid, Spain, November 5-8th, 2011. Congress   Program and Schedule of Events, page 119 (W18).
Ethgen O. A risk forecasting model to help in the   designing of risk-sharing schemes. 13th   European Congress of the International Society for Pharmacoeconomics and   Outcomes Research (ISPOR) – Prague, Czech Republic, November 6-9th,   2010. Value in Health 2010;13:A241.
Ethgen O, Connolly M, Postma M. Considering health   as an investment rather than a cost – Alternative modelling approaches to   demonstrate economic value.  Workshop   at the 13th European Congress of the International Society for   Pharmacoeconomics and Outcomes Research (ISPOR) – Prague, Czech Republic,   November 6-9th, 2010. Congress Program and Schedule of Events,   page 99 (W9).
Ethgen O, Staginnus U. Making the most of   risk-sharing schemes: Access strategies, risk analytics and tactical sharing   approaches. Workshop at the 13th   European Congress of the International Society for Pharmacoeconomics and   Outcomes Research (ISPOR) – Prague, Czech Republic, November 6-9th,   2010. Congress Program and Schedule of Events, page 102 (W23).
Ethgen O. Modelling and practical approaches to risk-sharing.   HTAi Policy Forum on “Handling   uncertainty in HTA: International development in policy and practice, and   their implications for research” at the 32nd Annual Meeting of the   Society for Medical Decision Making (SMDM) – Toronto, Canada, October 24-27th,   2010.
Ethgen O. Risk-sharing analytics: Practical and   modelling approach. Parallel Panel   Session on “Risk-sharing approaches and patient-access schemes: translating   concept into real world settings” at the 7th Health Technology   Assessment International (HTAi) Annual Meeting – Dublin, Ireland, June 6-9th,   2010 Conference Program, page 74.
Ethgen O. Dynamic budget impact approach. Parallel Panel Session on “Health   technology assessment: What additional methodologies can we offer decision   makers” at the 7th Health Technology Assessment International   (HTAi) Annual Meeting – Dublin, Ireland, June 6-9th, 2010   Conference Program, page 74.
Ethgen O, Staginnus U. Designing   risk-sharing schemes: Opportunities, pitfalls and preliminary modelling. Workshop at the 12th European   Congress of the International Society for Pharmacoeconomics and Outcomes   Research (ISPOR) – Paris, France, October 24-27th, 2009. Congress   Program and Schedule of Events, page 108 (W15).
Ethgen O, Demarteau N, Standaert BA. Cohort   modelling – Is the approach too old for the elderly? 12th European Congress of the International Society for   Pharmacoeconomics and Outcomes Research (ISPOR) – Paris, France, October   24-27th, 2009. Value in Health 2009;12:A226.
Gao X, Snedecor S, Ethgen O,   Botteman M. Impact   of including cardiovascular outcomes on estimates of clinical and economic   benefits of influenza vaccination in the US elderly population. 14th International Congress of   the International Society for Pharmacoeconomics and Outcome Research (ISPOR) –   Orlando (FL), USA, May 16-20th, 2009. Value in Health 2009;12:A13.
Hiligsmann   M, Bruyère O, Ethgen O, Reginster JY. Cost-utility   of strontium ranelate in the treatment of postmenopausal women. 8th   European Congress on Clinical and Economic Aspects of Osteoporosis and   Osteoarthritis (ECCEO) – Istanbul, Turkey, April 9-12th, 2008.   Osteoporosis International 2008;19 Suppl.1:S5.
Hiligsmann   M, Bruyère O, Ethgen O, Reginster JY. Cost-effectiveness   of bone densitometry screening combined with alendronate therapy for those   who have osteoporosis. 10th   European Congress of the International Society for Pharmacoeconomics and   Outcome Research (ISPOR) – Dublin, Ireland, October 20-23rd, 2007.   Value in Health 2007;10:A236.
Ethgen O, Lamotte M, Annemans L. Health economic   evaluation of bivalirudin in the management of patients undergoing   percutaneous coronary intervention in Belgium. 8th European Congress of the International Society for   Pharmacoeconomics and Outcome Research (ISPOR) – Florence, Italy, November   6-8th, 2005. Value in Health 2005;8:A11.
Ethgen O, Moeremans K, Annemans L. Economic aspects   of hospital malnutrition [French]. 13th   Meetings of Clinical Nutrition – Durbuy, Belgium, June 2-3 2005.
Ethgen O. The   impact of osteoarthritis on quality of life [French]. Osteoarticular   diseases: Multidisciplinary approach, treatments and quality of life –   Department of Public Health Sciences, University of Liège – Liège, Belgium,   September 11, 2003.
Ethgen O, Fraikin G, Reginster JY. Epidemiology   of osteoarthritis and osteoporosis. International   Congress on Genetics of Osteoarticular Disorders – Florence, Italy, February   22-23rd, 2002. Fondazione Internationale Menarini Symposia N°162 –   February 2002.
Ethgen O, Tellier V, Ben SedrineW, De Maeseneer J,   Gosset C, Reginster JY. Health-related   quality of life and cost of ambulatory care in osteoporosis. May such outcome   measures be valuable information to health decision makers and payers? 2nd International Meeting on   Social and Economic Aspects of Osteoporosis and Bone Diseases – Liège,   Belgium, December 7-9th, 2000. Osteoporosis International 2000;11   Suppl.5:S5.
Ethgen O, Kahler KH, Kong SX, Reginster JY, Wolfe F. Are   health-related quality of life scores useful in predicting the use of health   care services? Exploration in patients with arthritis. 64th American College of Rheumatology annual scientific   meeting (ACR) – Philadelphia, PN, USA, November 12-16th, 2000.   Arthritis and Rheumatism 2000;43 Suppl.1:S163.